Castor Videos

As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these trials more and more, researchers have come to appreciate the significance of establishing uniform approaches for evaluating and analyzing real-world data (RWD).

As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these trials more and more, researchers have come to appreciate the significance of establishing uniform approaches for evaluating and analyzing real-world data (RWD).

As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these trials more and more, researchers have come to appreciate the significance of establishing uniform approaches for evaluating and analyzing real-world data (RWD).

As we kick-off 2023 with a refreshed mindset, we take inventory of what is important and focus on our goal to continuously make sure that we are maximizing the impact of data on the global disease burden with more inclusive, patient-friendly trials.

There are ongoing debates about whether or not our industry should call all decentralized ones digital trials; however, most of us need help understanding the fundamental step to successfully operate both types of trials, which is effective data monitoring.

Many researchers are still hesitant to adopt digital informed consent due to a misconception that digital forms are too complex. Listen to this month’s Download with Derk to hear his perspective on the topic.

Listen to our CEO & Founder Derk Arts share his thoughts about why remote-first is the only way forward and what we can lean into right now to achieve it.

In this first release of Download with Derk, our CEO & Founder discussed best practices for effective collaboration between clinical trial sites, CROs, and Sponsors.